$BLMH.c reports strong revenues and raises over $1M Earlier this month, Bloom Health Partners (CSE: BLMH) successfully closed the first tranche of its $2 million private placement, for gross proceeds of $1.03 million. On top of this, the company recently reported a very strong second quarter, highlighting revenue of $11.1 million.
For a company currently valued at only $7.42 million, both of these metrics are pretty impressive. Bloom has stated yearly guidance of up to $28 million in revenue, which would put its earnings at around 4x the current valuation. If you ask me, this is a pretty solid indicator that this company is highly undervalued atm.
In May, the company presented at the U.K. MedTech Trade Mission, which has me curious to see if we will see any announcements from the company regarding contract acquisitions across the pond.
Despite a recent dip, $BLMH has been performing relatively well contrary to the current bearish market. The company is currently up 30% from recent lows in late May, trading at $.19.
https://ceo.ca/@newsfile/bloom-health-partners-announces-closing-of-first-tranche